JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iversen, L. L.
Right arrow Articles by Axelrod, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iversen, L. L.
Right arrow Articles by Axelrod, J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 150, Issue 2, 173-183, 1965
Copyright © 1965 by American Society for Pharmacology and Experimental Therapeutics


THE UPTAKE AND STORAGE OF H3-NOREPINEPHRINE IN THE RESERPINE-PRETREATED RAT HEART

L. L. Iversen 1, J. Glowinski 1, and J. Axelrod 1

1 Laboratory of Clinical Science, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland

The ability to accumulate tracer amounts of H3-norepinephrine in the rat heart returns to almost normal 48 hours after the administration of reserpine. However, at this time the tissue was unable to retain large amounts of exogenous norepinephrine. In the isolated perfused heart the rate of uptake of H3-norepinephrine from the perfusing medium was unaffected at any time after reserpine treatment. In the isolated tissue preparation and in the whole animals the retention of H3-norepinephrine in the heart was severely depressed after reserpine. In reserpine-pretreated hearts H3-norepinephrine was accumulated mainly in the supernatant fraction. Once taken up, the H3-norepinephrine in the reserpine-pretreated heart is rapidly metabolized by monoamine oxidase, presumably because it cannot be protected by binding in nerve storage granules. The accumulation of H3-norepinephrine in the reserpine-pretreated heart can be inhibited by tyramine but not by DMI, and increased by treatment with a monoamine oxidase inhibitor. There is a small store of H3-norepinephrine in the reserpine-pretreated heart which can be partially released by DMPP and reserpine but not by tyramine.

Accepted on June 17, 1965




This article has been cited by other articles:


Home page
ScienceHome page
J. J. Schildkraut and S. S. Kety
Biogenic Amines and Emotion
Science, April 7, 1967; 156(3771): 21 - 30.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1965 by the American Society for Pharmacology and Experimental Therapeutics.